# Amylyx Pharmaceuticals, Inc.: Form 8-K, filed Nov 2, 2022

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: 8-K
- Filed: 2022-11-02
- Accepted by EDGAR: Nov 2, 2022, 16:01 ET
- Period: 2022-11-01
- Accession: 0001193125-22-275812
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000119312522275812/d374833d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000119312522275812/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000119312522275812/d374833d8k.htm

Filed Nov 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-275812. Last ingested by Listed: Nov 13, 2026, 14:43 ET. No prices; not investment advice.
